Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Allakos Inc (ALLK)
NASDAQ:ALLK
Allakos (ALLK) Stock Price & Analysis
168 Followers
ALLK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.54 - $8.73
Previous Close$7.37
Volume488.38K
Average Volume (3M)1.09M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$325.32M
Total Debt (Recent Filing)$49.84M
Price to Earnings (P/E)-1.1
Beta-0.27
Next EarningsFeb 28, 2023
EPS Estimate-$0.5
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$12.33
EPS (TTM)-6.76
Shares Outstanding85,203,597
R-Squared0.00793
Standard Deviation0.31
10 Day Avg. Volume892,300
30 Day Avg. Volume1,090,208
Price to Book (P/B)1.93
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside67.30% Upside
Rating ConsensusModerate Buy
Alpha0.02
Number of Analyst Covering4
Allakos News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ALLK FAQ
What was Allakos’s price range in the past 12 months?
Allakos lowest stock price was $2.54 and its highest was $8.73 in the past 12 months.
What is Allakos’s market cap?
Currently, no data Available
When is Allakos’s upcoming earnings report date?
Allakos’s upcoming earnings report date is Feb 28, 2023 which is in 29 days.
How were Allakos’s earnings last quarter?
Allakos released its earnings results on Nov 07, 2022. The company reported -$0.53 earnings per share for the quarter, beating the consensus estimate of -$0.755 by $0.225.
Is Allakos overvalued?
According to Wall Street analysts Allakos’s price is currently Undervalued.
Does Allakos pay dividends?
Allakos does not currently pay dividends.
What is Allakos’s EPS estimate?
Allakos’s EPS estimate is -$0.5.
How many shares outstanding does Allakos have?
Allakos has 85,203,600 shares outstanding.
What happened to Allakos’s price movement after its last earnings report?
Allakos reported an EPS of -$0.53 in its last earnings report, beating expectations of -$0.755. Following the earnings report the stock price went up 15.523%.
Which hedge fund is a major shareholder of Allakos?
Among the largest hedge funds holding Allakos’s share is Fairmount Funds Management Llc. It holds Allakos’s shares valued at 901K.
---
Allakos Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.33
$12.33
Blogger Sentiment
Bullish
ALLK Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 33.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 4.2%
Last 30 Days ▼ 4.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.87%
12-Months-Change
Fundamentals
Return on Equity
-85.49%
Trailing 12-Months
Asset Growth
-32.61%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Allakos Inc
Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in Redwood, CA.
---
Anavex Life Sciences
―
iTeos Therapeutics
―
Mirum Pharmaceuticals
―
Editas Medicine
―
POINT Biopharma Global
―
---